Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: Is it different than in HIV-uninfected persons?

Authors

F. M. Gordin
D. L. Cohn
J. P. Matts
R. E. Chaisson
R. J. O'Brien

Document Type

Journal Article

Publication Date

2004

Journal

Clinical Infectious Diseases

Volume

39

Issue

4

Inclusive Pages

561-565

APA Citation

Gordin, F., Cohn, D., Matts, J., Chaisson, R., & O'Brien, R. (2004). Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: Is it different than in HIV-uninfected persons?. Clinical Infectious Diseases, 39 (4). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_medicine_facpubs/2338